Harrow Health, Inc. (HROW) Ownership

NASDAQ: HROWTop holders, insider trades and short interest.

HROW ownership summary

as of October 18, 2026
Institutions
58.6%
of shares outstanding
Insiders
15.38%
of shares outstanding
Shares outstanding
37.5M
Float
28.9M
shares available to trade
Short interest
23.04%
7.8M shares short
Days to cover
13.98
short interest up 3.7% vs prior month
  • Institutions 58.59%
  • Insiders 15.38%
  • Other investors 26.03%

HROW top institutional holders

20 largest
Harrow Health, Inc. top institutional holders
#Holder% of sharesSharesValueChangeReported
1BlackRock Inc7.31%2.7M$74.8M+187,358 (+7.3%)June 30, 2026
2Opaleye Management Inc6.40%2.4M$65.5M−432,230 (−15.3%)June 30, 2026
3Private Capital Management, LLC4.26%1.6M$43.6M+36,770 (+2.4%)June 30, 2026
4Vanguard Capital Management, LLC3.78%1.4M$38.7M+14,156 (+1.0%)June 30, 2026
5Deep Track Capital, LP2.58%969K$26.4M+969,000 (0.0%)June 30, 2026
6State Street Corp2.51%940K$25.6M+84,841 (+9.9%)June 30, 2026
7Geode Capital Management, LLC2.42%906K$24.7M+53,526 (+6.3%)June 30, 2026
8BAMCO Inc2.16%809K$22.1M+809,350 (0.0%)June 30, 2026
9Dimensional Fund Advisors, Inc.1.78%667K$18.2M+87,516 (+15.1%)June 30, 2026
10Jupiter Topco LLC1.54%579K$15.8M+579,127 (0.0%)June 30, 2026
11Divisadero Street Capital Management, LP1.17%439K$12.0M+439,155 (0.0%)June 30, 2026
12Rice Hall James & Associates, LLC1.03%388K$10.6M+19,368 (+5.3%)June 30, 2026
13Marshall Wace Asset Management Ltd0.99%369K$10.1M−275,483 (−42.7%)June 30, 2026
14Citadel Advisors Llc0.96%360K$9.8M+138,616 (+62.6%)June 30, 2026
15Northern Trust Corp0.86%323K$8.8M+26,341 (+8.9%)June 30, 2026
16Schonfeld Strategic Advisors LLC0.85%320K$8.7M+319,625 (0.0%)June 30, 2026
17Vanguard Portfolio Management, LLC0.85%319K$8.7M+29,735 (+10.3%)June 30, 2026
18Charles Schwab Investment Management Inc0.73%274K$7.5M+3,160 (+1.2%)June 30, 2026
19Vanguard Fiduciary Trust Co0.63%235K$6.4M+7,797 (+3.4%)June 30, 2026
20Westside Investment Management, Inc.0.60%224K$6.1M+38,125 (+20.5%)June 30, 2026

Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 20, 18 holders added 3.8M shares and 2 cut 708K.

HROW top mutual fund and ETF holders

20 largest
Harrow Health, Inc. top fund holders
#Holder% of sharesSharesValueChangeReported
1Vanguard MStar Total Stk Mkt Idx Invest2.67%1.0M$27.3M—August 31, 2026
2iShares Russell 2000 ETF2.23%837K$22.8M−9,664 (−1.1%)September 30, 2026
3Baron Discovery Institutional1.91%715K$19.5M+138,900 (+24.1%)September 30, 2026
4Janus Henderson Venture D1.25%470K$12.8M+1,670 (+0.4%)August 31, 2026
5Fidelity Small Cap Index0.94%354K$9.7M+3,144 (+0.9%)July 31, 2026
6iShares Russell 2000 Growth ETF0.80%301K$8.2M−381 (−0.1%)September 30, 2026
7State Street® SPDR® S&P® PhrmctlsETF0.74%277K$7.6M−3,446 (−1.2%)September 30, 2026
8Vanguard Russell 2000 ETF0.50%186K$5.1M+4,390 (+2.4%)August 31, 2026
9Schwab US Small-Cap ETF™0.45%169K$4.6M+108 (+0.1%)September 30, 2026
10Fidelity Extended Market Index0.44%164K$4.5M−1,867 (−1.1%)August 31, 2026
11DFA US Small Cap I0.40%148K$4.0M—August 31, 2026
12Fidelity Enhanced Small Cap Core ETF0.39%146K$4.0M+306 (+0.2%)September 30, 2026
13Dimensional US Small Cap ETF0.34%126K$3.4M—September 30, 2026
14Private Capital Management Value I0.34%126K$3.4M—June 30, 2026
15DFA US Micro Cap I0.34%126K$3.4M+8,244 (+7.0%)August 31, 2026
16JNL Multi-Manager Small Cap Growth A0.32%120K$3.3M+120,054 (0.0%)June 30, 2026
17iShares US Pharmaceuticals ETF0.31%116K$3.2M+357 (+0.3%)September 30, 2026
18Royce Small-Cap Growth Growth Svc0.28%106K$2.9M+66,353 (+167.1%)June 30, 2026
19Principal US Small Cap ETF0.28%105K$2.9M+52 (+0.0%)September 30, 2026
20iShares Micro-Cap ETF0.27%102K$2.8M−705 (−0.7%)September 30, 2026

Funds report holdings monthly or quarterly; dates differ by fund.

HROW insider transactions

latest 10
Harrow Health, Inc. insider transactions
DateNameTransactionPriceSharesValue
2024-04-25Opaleye Management Inc.Buy$9.9720,000$199,400
2024-04-23Opaleye Management Inc.Buy$10.2911,715$120,547
2024-04-19Opaleye Management Inc.Buy$10.5629,400$310,464
2024-03-28Opaleye Management Inc.Buy$12.8250,000$641,000
2024-03-22Mark L BaumBuy$11.599,000$104,310
2024-03-20Opaleye Management Inc.Buy$9.6550,600$488,290
2023-11-16Mark L BaumBuy$8.117,500$60,825
2023-09-19Opaleye Management Inc.Buy$14.6514,017$205,349
2023-08-14Mark L BaumBuy$17.055,800$98,890
2023-08-14Martin A MakaryBuy$16.9220,000$338,400

Reported trades by company officers, directors and other filers (including disclosures by members of Congress where EODHD lists them). "—" where the filing gives no share count.

HROW shares outstanding

Shares outstanding

Year-end shares outstanding, adjusted for splits.

Who owns HROW

Institutional investors own 58.6% of Harrow Health's shares and insiders 15.38%. The largest holder is BlackRock Inc with 7.31% of the shares (2.7M), as of June 30, 2026. Among the top 20 institutions, 18 added shares and 2 reduced their stake in the latest filings. Short interest is 23.04% of the float, or 13.98 days of average trading volume. The share count rose 293.7% since 2014.

Related: HROW analyst forecast, HROW key metrics. See the HROW stock overview for the latest quote and news.

HROW ownership FAQ

Who owns the most Harrow Health stock?

The largest shareholders of Harrow Health are BlackRock Inc (7.31%), Opaleye Management Inc (6.40%), Private Capital Management, LLC (4.26%), Vanguard Capital Management, LLC (3.78%), Deep Track Capital, LP (2.58%).

What percentage of Harrow Health is owned by institutions?

Institutions hold 58.6% of Harrow Health's shares outstanding; insiders hold 15.38%.

Which funds own Harrow Health?

The largest fund holders of Harrow Health are Vanguard MStar Total Stk Mkt Idx Invest (2.67%), iShares Russell 2000 ETF (2.23%), Baron Discovery Institutional (1.91%), Janus Henderson Venture D (1.25%), Fidelity Small Cap Index (0.94%).

What is Harrow Health's short interest?

7.8M shares of Harrow Health were sold short, 23.04% of the float; at the average daily volume it would take 13.98 days to cover.

Are insiders buying or selling Harrow Health?

Of the latest 10 reported insider transactions in Harrow Health (since August 14, 2023), 10 were purchases and 0 were sales.

How many shares of Harrow Health are outstanding?

Harrow Health has 37.5M shares outstanding, of which 28.9M are in the public float.

Drug Manufacturers - Specialty & Generic: ownership